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Abstract 
 
BACKGROUND: The poultry red mite (PRM) Dermanyssus gallinae is the most common 
ectoparasite on poultry and causes high economic losses in poultry farming worldwide. 
Pyrethroid acaricides have been widely used for its control and, consequently, pyrethroid 
resistance has arisen. In this study we aim to investigate the occurrence of resistance and 
study the geographical distribution of pyrethroid resistance mutations across PRM 
populations in Europe. 
 
RESULTS:  Full  dose-response  contact  bioassays  revealed  very  high  levels  of  resistance 
against several pyrethroids (α-cypermethrin, fluvalinate and cyfluthrin) in two PRM 
populations from Greece, compared to a susceptible reference strain. Resistance was 
associated with mutations in the gene encoding the target-site of pyrethroids, the voltage- 
gated sodium channel (VGSC). Mutations, M918L and L925V in domain IIS4-S5 and F1534L in 
domain IIIS6, were found at positions known to play a role in pyrethroid resistance in other 
arthropod species. Subsequent screening by sequencing VGSC gene fragments IIS4-S5 and 
IIIS6 revealed the presence and distribution of these mutations in many European 
populations. In some populations, we identified additional or different mutations including 
M918V/T, L925M, T929I/F, I936F and F1538L. The latter mutation is a possible alternative 
for F1538I that has been previously associated with pyrethroid resistance in other mites and 
ticks. 
 
CONCLUSION: We report very high levels of pyrethroid resistance in PRM populations from 
Greece, as well as the identification and geographical distribution of ten pyrethroid 
resistance mutations in PRM populations across Europe. Our results draw attention to the 
need for an evidence-based implementation of PRM control, taking acaricide resistance 
management into consideration. 
 
1 INTRODUCTION 
 
The poultry red mite (PRM), Dermanyssus gallinae (De Geer, 1778), is recognized as the 
most important blood sucking ectoparasite of laying hens and broiler birds worldwide. It 
poses an important threat to animal welfare but, to a lesser extent, also to public health1.  A 
PRM infestation affects birds by causing feather pecking, anaemia, restlessness, aggression, 
reduced egg production (increased fragility of the egg shell), blood staining of the eggs or 
transmission of pathogenic agents.1,2 The economic impact of PRM was approximately 130 
million euros in 2004 and increased to an estimation of 231 million euros in 2017.3 Over 80% 
of European layer farms are infested with PRM. More specifically, more than 90% of Dutch, 
German and Belgian layer farms and most Northern Greek farms are infested with PRM.4,5 
PRM infestations have also been reported in China, Japan, Australia and Brazil.6  The high 
 
PRM infestation rates in Europe may be associated with recent legislation for the 
transformation of housing systems in laying hen husbandry in EU member countries, as well 
as the withdrawal of many acaricide products from the market, due to strict legislation and 
safety concerns.3 
 
The control of PRM populations is primarily based on acaricide applications (sprays, mists 
and dusts) and a small number of alternative options, including biological control (e.g. 
acaripathogenic  fungi,  predatory  mites)  and  biopesticides  (e.g.  plant  extracts).7    Few 
acaricide products are however registered for the control of PRM in Europe, depending on 
the local market and legislation, including organophosphates (phoxim), pyrethroids 
(cypermethrin, permethrin, deltamethrin), carbamates (bendiocarb), amidines, isoxazolines 
(fluralaner), abamectin and spinosad.3,8,9 
 
The extensive use of these acaricides and the life history traits of PRMs (short life cycle and 
high fecundity) have resulted in the development of acaricide resistance. There have been 
many reports of PRM resistance against acaricides, mainly for pyrethroids: Italy in 1984 and 
2009 (permethrin)10,11; former Czechoslovakia in 1985 (α-cypermethrin)12; France in 1996 
 
(permethrin)13;  Sweden  in  2000  (permethrin)14  and  Poland  in  2010  (α-cypermethrin)15. 
 
Other unsuccessful attempts of PRM control using acaricides were reported in Germany, UK 
 
and Hungary.16 
 
Pyrethroid resistance has been investigated at the molecular level in Acari and can be 
metabolism-based, i.e. faster or more efficient detoxification of the active ingredient that 
reduces target exposure. This has been inferred indirectly as shown by synergism 
experiments, but also metabolism assays.17,18  On the other hand, resistance has also been 
linked to alterations in the target site of pyrethroids, the voltage-gated sodium channel 
(VGSC).19,20  A number of VGSC mutations have been characterised to-date in several Acari 
and  insect  species, including  those  located  at  transmembrane segments 4  to  5  of  the 
domain II (IIS4-IIS5) region of the VGSC gene at amino acid positions M918, L925, T929 and 
I936, as well as mutations located in IIIS6, at amino acid positions F1534 and F1538 (Figure 
1) (Musca domestica numbering).19  In the cockroach, Blatella germanica, F1538I has been 
 
associated with a very strong pyrethroid insensitivity phenotype21  and this mutation has 
been found to be common in mites and ticks, such as Tetranychus urticae and Rhipicephalus 
microplus.22–24 On the other hand, M918T, also known as the super-kdr mutation and known 
to confer strong resistance against pyrethroids19, has been identified in the VGSC of 
pyrethroid resistant spider mite species.25,26  Finally, certain mutations appear to enhance 
the pyrethroid resistance phenotype conferred by others, rather than being directly causal, 
while  it  is  also  possible  that  they  play a  role  in  improving the fitness  of  the  mutated 
allele.19,27 
 
Molecular mechanisms of pyrethroid resistance have not yet been investigated in PRM but 
the recently released PRM whole genome sequence28 now provides a unique opportunity to 
investigate acaricide resistance mechanisms in this mite species. In this study, we associated 
pyrethroid  resistance phenotypes with  mutations  in  the  VGSC  genotypes and  surveyed 
these mutations in European PRM populations. 
 
2 MATERIALS AND METHODS 
 
2.1 PRM populations 
 
The susceptible PRM strain (SUSC) is a laboratory strain, that has been maintained at the 
Institute for Parasitology of the University of Veterinary Medicine Hannover (Germany) and 
has not been exposed to acaricides for several decades.29 The GRC and BEL samples of PRM 
were collected in 2018 from 6 locations around Athens, Greece and 2 locations in Belgium 
respectively (Table 1). The GRC1, GRC2, GRC5 strains were collected from heavily sprayed 
poultry farms near Athens (Megara and Ilion), while the GRC6 and the BEL1, BEL2 strains 
were sampled from private housing coops in Greece and Belgium, respectively. Additional 
samples were collected from different European regions, primarily from large poultry farms, 
with acaricide application history. The mites were collected either alive in plastic boxes 
containing mites of all developmental stages (samples from Greece, Belgium and Germany) 
or in ethanol (the remaining European populations). 
 
2.2 Bioassays 
 
Laboratory tests to assess pyrethroid susceptibility were conducted by exposing mites in 
treated glass vials. Technical grade pesticide was dissolved in acetone, diluted and 0.5 mL of 
solution was transferred into individual 20 mL glass vials. Vials were rolled on their sides 
until the acetone evaporated, leaving a uniform film of acaricide on the inner surface. 
Technical  grade  α-cypermethrin,  cyfluthrin  and  fluvalinate  were  obtained  from  Sigma 
Aldrich. Approximately ten mites (3 day-starved deutonymphs) were placed in each vial, 
after which it was kept in an incubator at 25 °C for 20h. After the treatment, mites were 
evaluated individually and considered dead in absence of leg movement when prodded. 
Toxicity data were analyzed using PoloPC (LeoRA, Software, Berkeley, CA). 
 
2.3 DNA & RNA extraction, amplification and sequencing 
 
Genomic  DNA  was  extracted  from  pools  of  approximately  50  mites  per  sample,  using 
DNAzol reagent (Molecular Research Center, Inc.) according to the manufacturer’s 
instructions. The mites were collected alive (GRC, GER and BEL samples) or washed from 
ethanol with distilled water (remaining EU samples) before further treatment. Pooled mites 
were grinded with pestles in 500 ul DNAzol in 1.5 ml Eppendorf tubes. The samples were 
 
centrifuged at approximately 10,000 g for 10 min at room temperature. The supernatant 
was transferred in a new tube and mixed with 250 ul of 100% ethanol. After 20 min 
centrifugation at approximately 13,000 g at room temperature, the supernatant was 
discarded, and the pellet washed with 1 ml of 75% ethanol. Then the samples were 
centrifuged for 5 min at approximately 13,000 g at room temperature, the supernatant was 
discarded, and the pellet was air dried and finally dissolved in 20 ul sterile water. 
 
Two fragments of the VGSC were amplified: domain IIS4-S5 (145 bp) and domain IIIS6 (237 
bp). PCR reactions were initiated with approximately 200 ng of gDNA as template, in 1 x Taq 
reaction buffer (Promega, SB Biotechnology Suppliers S.A. Athens, Greece), using 2 pairs of 
primers  (KF1  5’-CAAGTCATGGCCGACGTTGA-3’, KR1  5’-GTCGGTGTAGTTCTTGCCGAA-3’ for 
the amplification of IIS4-IIS5 and KF3 5’-AAAAGACGACCAGCCCGACT-3’, KR3 5’- 
GGTATGGCTTTGGCGGGTTT-3’for the amplification of IIIS6) with a final concentration of 2 
mM MgCl2 and 0.5 mM of each primer. The PCR reactions were performed under the 
following conditions for both primer pairs: 94 °C for 3 min, then 35 cycles of 95 °C for 30 sec, 
56 °C for 30 s, 72 °C for 30 sec, followed by a final cycle of 72 °C for 2 min. Primers were 
designed based on the VGSC gene sequence from the recently published PRM genome28 and 
used to PCR amplify partial sequences of the PRM VGSC gene. PCR products were purified 
using NucleoSpin Extract II (Macherey-Nagel) and directly sequenced from both sides with 
the original PCR primers. Sequencing reactions were performed at CeMIA SA (University of 
Thessaly, Greece). Sequence data were analysed using Bioedit 7.0.1 30 and compared to the 
sequence of the susceptible strain (SUSC). For the SUSC, GR1, GR2 populations, the IIS6 
domain was amplified additionally to the IIS4-IIS5 and IIIS6. Total RNA was extracted from 
mass homogenates of PRM using TRI reagent (Sigma-Aldrich, Bornem, Belgium) according to 
the manufacturer’s instructions. The RNA was treated with DNase (Turbo DNase, Ambion) 
and 2 μg RNA for each sample was reverse transcribed into cDNA using SuperScript™ III 
Reverse Transcriptase (Invitrogen) and oligo(dT)20. One pair of primers was used for the 
amplification of the VGSC domains IIS4-IIS6 (430 bp) (KF1 5’-CAAGTCATGGCCGACGTTGA-3’ 
and KR4 5' CTCCTGCAGCTTCTTCGTGT 3'). The PCR reaction was performed with the same 
 
reagent concentrations as above mentioned, and under the following conditions: 94 °C for 3 
min, then 35 cycles of 95 °C for 30 sec, 58 °C for 30 s, 72 °C for 30 sec, followed by a final 
cycle of 72 °C for 2 min. Sequencing reactions and analysis were performed as described 
previously. 
 
3 RESULTS 
 
3.1 Characterization of pyrethroid resistance in GRC1, GRC2 and the susceptible strain 
 
SUSC 
 
We have first investigated pyrethroid resistance in two PRM populations, GRC1 and GRC2, 
collected in 2018 from large poultry houses near Athens (Megara and Ilion, Greece, 
respectively). The GRC1 population exhibited high levels of resistance to α-cypermethrin, 
cyfluthrin and fluvalinate (resistance ratio > 1,000,000-fold) while the GRC2 population 
exhibited high levels of resistance to α-cypermethrin, compared to the susceptible strain 
SUSC  (Table  1).  The  LC50    of  α-cypermethrin,  cyfluthrin  and  fluvalinate  in  the  GRC1 
population exceeded 1000 mg a.i./L, and the LC50 of α-cypermethrin in the GRC2 population 
was higher than 2000 mg a.i./L. In contrast, the LC50 of the susceptible laboratory strain was 
determined at 5.84*10-4 mg a.i./L for α-cypermethrin, 8.76*10-5 mg a.i./L for cyfluthrin and 
 
1.76*10-4 mg a.i./L for fluvalinate (Table 1). 
 
3.2 Identification of target site mutations associated with pyrethroid resistance 
 
The sequences of VGSC domain II (S4-S5-S6) and III (S6) were obtained from the recently 
available  PRM  genome  sequence  28.  None  of  the  previously  characterised  pyrethroid 
resistant mutations (Figure 1A) were present in domain II S4-S5 and III S6 of the VGSC from 
the susceptible strain SUSC. Subsequently, the respective sequences from the GRC1 and 
GRC2 populations that exhibited high resistance against pyrethroids were obtained and 
compared with the SUSC strain. Non-synonymous mutations were detected at codons 918, 
925 (domain II) and 1534 (domain III) in both GRC1 and GRC2 (M. domestica numbering, 
underlined triplets and deduced amino acids in Figure 1A), at positions which have been 
 
associated with pyrethroid resistance in other species. In the sample of pooled mites, both 
M918L  and  F1534L  appeared  fixed  in  the  GRC1  population,  while  M918L  and  L925V 
appeared fixed in the GRC2 population, which showed the strongest resistance phenotype. 
We did not observed any mutations in domain IIS6 in both GRC1 and GRC2, nor the SUSC 
strain. We use the term ‘fixed’ when sequencing chromatographs do not show any evidence 
of an alternative nucleotide at the position of interest, based on sequencing a PCR fragment 
amplified on pooled material. This does not necessarily mean complete fixation at the 
population level, as a large number of single mites needs to be assayed to support such 
claims. This limitation in assessing frequency estimates also implies for pooled samples in 
3.3. 
 
3.3 Monitoring the presence and frequency of pyrethroid resistance mutations in PRM 
 
populations across Europe 
 
We subsequently investigated the presence of M918L, F1534L and L925V, as well as possible 
additional pyrethroid resistance mutations, across PRM populations  from Europe. Fifty- 
three samples from 15 European countries were examined in total: Greece, Italy, France, 
Spain, Portugal, UK, Ireland, Czech Republic, Belgium, Netherlands, Denmark, Romania, 
Albania, Croatia, Germany and Turkey (Figure 2). More specifically, we analysed by direct 
sequencing of PCR products two fragments of the VGSC gene, parts of the domains II (IIS4- 
IIS5) and IIIS6. Resistant mutations were detected as double peaks (not fixed) or single 
peaks (fixed), indicating the presence of a mixture of resistant and susceptible alleles or 
fixed resistant/susceptible alleles only in each sample, respectively. But see the limitation in 
terminology outlined above. 
 
Except for the SUSC strain and the samples GER1 (Hannover, Germany) and GBR10 (West 
Sussex, UK) that bear no mutations in the examined domains, 50 out of 53 samples analysed 
had at least one mutation at amino acid positions previously associated with pyrethroid 
resistance (Table 2). Overall, eight putative pyrethroid resistance mutations were identified 
across all PRM populations at positions M918 (918L, 918V, 918T), L925 (925M, 925V), L929 
 
(925V and 925M), I936 (936F) in domain II and two additional ones, F1534L and F1538L in 
domain III (Figure 1B). The M918L substitution was the most frequently found, as it was 
identified in 37 out of 53 samples (69.8%) and the amino acid leucine was found to be the 
predominant allele in our samples at the 918 position. In contrast, the amino acid valine was 
identified at codon 918 (M918V) in only one out of 53 samples (NLD2, Netherlands) and 
amino acid threonine (M918T) was also rare (4 out 53 samples). L925V was also frequently 
detected in 19 out of 53 samples (35.8%), in contrast to methionine at the same position (3 
out of 53 samples). In general, the rarest substitutions were T929I and I936F in 4 samples 
each (7.5%) of the total. Two additional mutations were found in domain III, F1534L and 
F1538L (Table 2 and Figure 1A). F1534L was the most frequent mutation, as it was present 
in 31 out of 53 samples (58.5%). F1538L was found only in 3 samples (5.7%): two derived 
from the UK (GBR3, GBR9) and one from France (FRA). 
 
Focusing on the country level, PRM populations from three countries - Greece, Croatia and 
Albania - appear to have the same VGSC gene mutation profile, as in all of these populations 
M918L, L925V and F1534L were present (Figure 3). Samples originating from Portugal (PRT1, 
PRT2, PRT3, PRT4) and Spain (ESP1, ESP2, ESP3) also had a similar profile, as they all showed 
a combination of M918L with F1534L. The population collected from France (FRA) had the 
M918T and F1538L substitution. Additionally, in populations from Italy (ITA1, ITA2) we 
identified two mutations, M918L and L925V. The sample from Turkey (TUR) was the only 
population bearing the T929I mutation alone. T929I was also present in Romania (ROU1, 
ROU3, ROU4, ROU5, ROU6), along with M918L and F1534L. In samples from Czech Republic 
(CZE1, CZE2) M918L, L925M/V and I936F were present. In the Netherlands, all three most 
commonly found mutations were identified - M918L, L925V and F1534L - while M918V was 
only found in only one sample. Belgian samples appeared to have M918L, L925M, I936F and 
F1534L. The samples obtained from Denmark (DNK1, DNK2) harboured both M918L and 
L925V.  Last,  the  highest  diversity  of  mutations  was  found  in  UK  samples:  M918L/T, 
L925V/M, I936F, F1534L and F1538L. In addition, in two UK samples (GBR7, GBR8) we 
identified a point mutation (TTT to CTT, not fixed) at the 1537 position (phenylalanine to 
 
leucine, both hydrophobic amino acids), previously mentioned as a ‘pyrethroid sensing 
residue’31, suggesting it might require further investigation, as it was combined with already 
known resistance mutations. 
 
4 DISCUSSION 
 
High levels of pyrethroid resistance were detected in field populations (GRC1, GRC2) from 
Megara and Ilion respectively (Greece), where almost 40% of the country’s hen rearing is 
hosted. Resistance against α-cypermethrin, cyfluthrin and fluvalinate pyrethroids, acaricides 
which have been used extensively in Greece for several years, scaled over 10,000-fold, 
compared to a susceptible laboratory strain SUSC (Table1). 
 
A M918L mutation in domain IIS4-S5 of the VGSC gene was at very high frequency, looking 
fixed in the pooled sample of the GRC1 strain. M918L is a variant of the well-known super- 
kdr mutation (M918T)19,32 and has also been found in the spider mite T. urticae 26, while a 
M918T mutation has been associated with pyrethroid resistance in T. evansi.25 The M918L 
mutation alone confers moderate levels of resistance33, but when combined with other 
 
mutations, particularly at position L92534–37 provides higher resistance levels. A F1534L 
mutation was also present in GRC1. An alternative mutation at the same position, F1534S, 
has been identified in multi-resistant T. urticae population on different crops.26 On the other 
hand, a F1534C mutation has been identified in pyrethroid resistant mosquitoes38,39  and 
upon functional characterization in Xenopus oocytes was shown to confer increased levels 
of pyrethroid insensitivity.40 
 
Together with M918L, an L925V mutation appeared fixed in the GRC2 population, which 
probably showed even higher levels of pyrethroid resistance (LC50 > 2000 mg a.i./L). The 
L925V mutation, and a variant thereof (L925I) has been associated with resistance in several 
European populations of Varroa destructor, a mite belonging to the same superfamily 
(Mesostigmata:  Dermanyssoidea)  as  PRM41–43,  but  also  in  others  arthropod  species, 
including ticks and bedbugs.19,44,45 
 
We subsequently assessed the presence and frequency of pyrethroid resistance mutations 
in a large number of PRM populations across Europe (53 samples in total from 15 European 
countries), aiming to investigate the presence and geographical distribution of M918L, 
F1534L and L925V, as well as possibly additional mutations, in several countries where 
pyrethroid resistance cases had already been reported.1,11,13,16 Pyrethroid resistance 
mutations were widely spread across Europe, as only 3 out of 53 examined samples did not 
have any mutation in the VGSC domains (IIS4-S5 and IIIS6) that were investigated in this 
study. M918L and F1534L, mutations that were associated with the striking pyrethroid 
resistance phenotype in the GRC1 and GRC2 populations from Greece, were the most 
common mutations across Europe (37 out of 53 and 31 out of 53 samples, respectively). In 
some cases, the M918L and F1534L mutations were, like in the GRC1 population, detected 
in combination and both fixed in field populations from Portugal (PRT1, PRT2), UK (GBR2) 
and Romania (ROU21). In other cases, the M918L and the L925V mutations were, like in the 
GRC2 population, both present and fixed in populations from Greece (GRC3, GRC5, GRC6), 
UK (GBR1) and Italy (ITA2). 
 
A F1538L mutation in domain III, which has been associated with pyrethroid resistance in 
the pollen beetle Meligethes aeneus46, was detected in two samples originating from the UK 
and one from France. The role of a similar mutation, F1538I, in pyrethroid resistance has 
been confirmed by electrophysiological studies21 and was shown to confer very high levels 
of resistance to a number of pyrethroids in mites and ticks.24,47,48 In T. urticae, for example, 
F1538I was introgressed into a susceptible population and conveyed a strong pyrethroid 
resistance phenotype.23  Since both isoleucine and leucine amino acids are branched-chain 
amino acids and have a similar structure and physicochemical properties, the effect of the 
alternative mutation F1538L identified in PRM is likely to be equivalent to the effect of 
F1538I. However, the role of this mutation has to be functionally validated, alone or in 
combination with the other mutations identified in PRM. 
 
Interestingly, we also identified a F1537L mutation in two PRM samples from the UK (GBR7 
and GBR8). Although position F1537 has been  characterized as a pyrethroid sensing residue 
(also known as residue F3i1631, the F1537L has not yet been validated as a resistance 
mutations in any species so far. However, its position right next to the major pyrethroid 
resistance mutation F1538I in mite and tick VGSC genes may indicate its possible role in 
pyrethroid resistance and might warrant further investigation. 
 
The M918T mutation, the well-known super-kdr mutation that has been reported in T. 
evansi and numerous other pyrethroid resistant arthropod species19,25, was also found in 
GBR9 from the UK and together with F1538L was fixed in the population. This finding might 
indicate the presence of even more intense and broad pyrethroid resistance phenotypes in 
the UK. 
 
Another mutation, T929I, was detected and fixed in only one sample (TUR), in Turkey. T929I 
has been found in other species49. It has been functionally characterized in Xenopus and was 
shown to confer a drastic reduction of deltamethrin sensitivity 47,48. 
 
Although the sequencing/genotyping approach chosen in this study does not allow the 
identification of specific alleles, the co-occurrence of some mutations in the same allele was 
indirectly confirmed, as these mutations were found to be fixed in some populations. More 
specifically, the mutations M918L and F1534L were fixed in samples from Belgium, Greece, 
Portugal, Romania and UK, and thus presumably present on the same allele; the mutations 
M918L and L925V were fixed in a few samples originating from Greece, Italy and UK; the 
mutations M918T and F1538L were fixed in only one sample from the UK. As PRM is 
transmitted by dispersion between farms (on crates, egg trays or even humans) or, to a 
lesser extent, possibly by direct contact between birds50, it is likely that combinations of 
 
pyrethroid resistance mutations on certain alleles have been selected in one place as a 
single event, but subsequently spread across countries. This highlights the importance of 
passive transportation of PRM carrying resistance mechanisms, facilitated by human 
activities, which unfortunately promotes resistance spread at the world scale, as has been 
 
described in other species.51 This is also supported by similar mutation combinations found 
in neighbouring countries, as described above. Nevertheless, the precise worldwide 
haplotypic diversity, and thus the possible origin and expansion of resistant alleles, needs to 
be further investigated. 
 
Further studies are needed to better clarify the exact role of the reported mutations in 
resistance and the precise risk each allele possesses, as it is known from other species that 
the effect of certain mutations on the pyrethroid resistance phenotype, alone or in 
combination, largely varies in specificity, intensity and fitness. 19,27 
 
In addition, the possible contribution of additional non-target site resistance mechanisms in 
the striking resistant phenotypes observed in PRM cannot be excluded. Indeed, the 
combination of cytochrome P450 monooxygenase mediated metabolic resistance and target 
site resistance against pyrethroids has been found to be the most operationally significant in 
many species.27 The complexity of metabolic resistance may not facilitate the full 
understanding of detoxification pathways in the near future but at least some key candidate 
genes could now be identified, based on the recently acquired PRM genome.28 
 
Overall, the results obtained on the pyrethroid resistance status of European PRM 
populations and the wide distribution of resistant mutations and genotypes across several 
countries, as well as the apparent ease of PRM transmission between farms50, raise an 
animal welfare alarm in Europe. These results draw attention to regulate the use of 
pyrethroids, as well as additional acaricides for the reduction of PRM, taking acaricide 
resistance management into consideration. The development of DNA markers and the use 
of diagnostic tools will substantially facilitate screening and continuous monitoring of 
pyrethroid resistance alleles in poultry farms, providing critical evidence for resistance 
management,   in   order   to   limit   further   spreading   of   resistance   and   maintain   the 
effectiveness and sustainability of current control tools. 
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Figure Legends 
 
Figure 1. Mutations identified in segments of the PRM VGSC gene. 
 
A) Nucleotide triplets present in the sequenced VGSC gene segments of PRM. The triplets 
and amino acids identified in the GRC1 and GRC2 strains that were tested with bioassays are 
underlined. Triplets/amino acids found in the SUSC strain are indicated in normal font, while 
those found in the screened populations are indicated in bold font. B) Schematic diagram of 
domain II and III of the VGSC. Mutations found in PRM are indicated with orange stars, while 
those found in other species and indicated with black circles. Those mutations that were 
functionally characterized in Xenopus are framed in a grey box. 19 
 
Figure 2. Map showing the origin of 53 PRM populations analysed in this study, spread 
across 15 European countries. 
 
Figure 3. Schematic illustration of the distribution of pyrethroid resistance mutations in 
PRM populations across Europe. The classification of mutations was based on visual 
inspection of sequencing chromatographs and comprised three categories: ‘absent’, 
‘present’ and ‘fixed’ (when no alternative signal was detected at the investigated position). 
 
 
 
Table 1. Toxicity of pyrethroid acaricides towards three PRM populations (SUSC, GRC1 and GRC2). 
 
Treatment n* LC50 (95% CI)† Slope ± SE χ²‡ df RR50§ 
SUSC 
 
α-cypermethrin 
 
 
299 
 
 
5.84*10
-4 
(3.9*10
-4 
- 8.7*10
-4
) 
 
 
1.03±0.1 
 
 
4.75 
 
 
6 
 
 
- 
 
cyfluthrin 
 
187 8.76*10
-5 
(4.9*10
-5 
- 1.6*10
-4
) 
 
0.89±0.11 
 
2.39 
 
3 
 
- 
 
fluvalinate 
 
303 1.76*10
-4 
(9.7*10
-5 
- 3.2*10
-4
) 
 
0.65±0.07 
 
3.71 
 
4 
 
- 
 
GRC1 
 
α-cypermethrin 280 > 1,000 >1,000,000 
 
cyfluthrin 
 
215 
 
> 1,000 
 
>1,000,000 
 
fluvalinate 
 
260 
 
> 1,000 
 
>1,000,000 
 
GRC2 
 
α-cypermethrin 
 
123 
 
> 2,000 >1,000,000 
*number of mites tested. 
 
†LC, lethal concentration, expressed in mg a.i./L 
 
‡ χ², chi-square testing linearity 
 
 
§RR, Resistance Ratio = LC50 resistant strain (R) /susceptible strain (SUSC) 
 
Vejle DNK1 M/L L/V T I F F 
Jylland DNK2 M/L L/V T I F F 
 
Table 2. Amino acid substitutions in two VGSC domains (II and III) of European PRM populations. The 
non- wild type alleles are indicated with bold font. A forward slash, separating amino acids, indicates 
that the allele is not fixed in a certain PRM population. 
 
Country Region Code  VGSC domain II   VGSC domain III 
M918  L925 T929 I936 F1534 F1538 
Germany 
Hannover SUSC M L T I F F 
Hannover GER1 M L T I F F 
Megara GRC1 L L T I L F 
Ilion GRC2 L V T I F F 
Greece Megara                        GRC3                 L             V             T             I              F                F 
Megara                        GRC5                 L             V             T             I              F                F 
Avlona                         GRC6                 L             V             T             I              F                F 
Belgium 
Destelbergen BEL1 M/L L/M T I/F F/L F 
  Evergem  BEL2  L  L  T  I  L  F   
Zezerovo PRT1 L L T I L F 
 
Portugal 
Souto da Carpalhosa PRT2   L L T I  L F 
Riviera PRT3 M/L L T I F/L F 
   Casa de Hounance   PRT4  M/L  L  T  I  F/L  F   
Dungannon-Ireland GBR1  L V T I   F F 
Eastsussex GBR2 L L T I L F 
Lincolnshire GBR3 T/L L T I F/L F/L 
Durham GBR4 L L/V T I F/L F 
 
UK 
 
 
 
 
 
 
 
 
Albania 
 
 
 
Czech 
Republic 
Shropshire  GBR5  M/T L/M T   I  F  F 
Dungannon-Ireland  GBR6   M/L  L T I/F F  F 
Kent GBR7  M  L    T  I/F  F  F 
Suffolk   GBR8      L   L  T     I    F/L  F 
Cheshire   GBR9   T    L     T   I  F    L 
West Sussex  GBR10     M   L  T     I     F  F 
Peshkopi    ALB1   L   L/V    T   I    F/L    F 
Lushnye   ALB2  L  L/V   T    I   F/L   F 
Shkoder   ALB3  L  L/V   T    I   F/L   F 
Durres  ALB4  L  L/V   T   I   F/L  F 
Berat ALB5 L  L/V  T  I  F/L F 
Korca  ALB6  L L/V  T  I  F/L  F 
South Moravian region CZE1 M/L  L/V T  I F F 
Bohemia CZE2  M L/M T F F F 
Turkey  Karacaali  TUR M L  I I   F F 
Marchena, Seville ESP1  L L  T I F/L F 
Spain Marchena, Seville ESP2 L L T I F/L F 
  Marchena, Seville   ESP3   L  L  T  I  F/L  F   
Zagreb HRV1 M/L L T I F/L F 
 
Croatia 
 
 
 
 
Netherlands 
Zagreb HRV2 M L T I F/L F 
Zagreb  HRV3  M/L  L  T  I  F/L  F 
Zagreb  HRV4 M/L  L/V T  I  F/L  F 
Lutten NLD1 M/L L/V T  I  F/L F 
Barneveld  NLD2   M/V  L  T  I  F/L  F 
Barneveld  NLD3  M/L  L  T  I  F/L  F 
  Aalten  NLD4  M  L  T  I  F/L  F   
  France  Grenade  FRA  M/T  L  T  I  F  F/L   
 
Denmark 
 
 
 Tatarlaua ROU1 L L T I L F 
Cuzdrioara ROU3 M L T/I I F F 
Romania Cuzdrioara ROU4 M L T/I I F/L F 
 Cuzdrioara ROU5 M L T/I I F/L F 
  Floresti  ROU6  M/L  L  T  I  L  F   
Italy 
Lecce ITA1 M/L L/V T I F F 
Cremona ITA2 L V T I F F 
 
 
 
 
Figure 1. Mutations identified in segments of the PRM VGSC gene. 
A) Nucleotide triplets present in the sequenced VGSC gene segments of PRM. The triplets and amino 
acids identified in the GRC1 and GRC2 strains that were tested with bioassays are underlined. 
Triplets/amino acids found in the SUSC strain are indicated in normal font, while those found in the 
screened populations are indicated in bold font. B) Schematic diagram of domain II and III of the 
VGSC. Mutations found in PRM are indicated with orange stars, while those found in other species 
and indicated with black circles. Those mutations that were functionally characterized in Xenopus 
are framed in a grey box. 19  
 
Figure 2. Map showing the origin of 53 PRM populations analysed in this study, spread across 15 
European countries.  
 
Figure 3. Schematic illustration of the distribution of pyrethroid resistance mutations in PRM 
populations across Europe. The classification of mutations was based on visual inspection of 
sequencing chromatographs and comprised three categories: ‘absent’, ‘present’ and ‘fixed’ (when 
no alternative signal was detected at the investigated position). 
